Retour à l'accueil - Logo CERMN

EA 4258 | Centre d'études et de recherche sur le médicament de Normandie

Home > Scientific output > Publications > 2016


Publications 2016

(132)     Jouanne, M.; Voisin-Chiret, A. S.; Legay, R.; Coufourier, S.; Rault, S.; Sopkova-de Oliveira Santos, J. ß-Strand Mimicry: Exploring Oligothienylpyridine Foldamers. European J. Org. Chem. 2016, 2016, 5686–5696.
doi: 10.1002/ejoc.201600882

(131)     Wilson, T. C.; McSweeney, G.; Preshlock, S.; Verhoog, S.; Tredwell, M.; Cailly, T.; Gouverneur, V. Radiosynthesis of SPECT Tracers via a Copper Mediated 123 I Iodination of (Hetero)aryl Boron Reagents. Chem. Commun. 2016, 52, 13277–13280.
doi: 10.1039/C6CC07417K

(130) Saleh, N.; Saladino, G.; Gervasio, F. L.; Haensele, E.; Banting, L.; Whitley, D. C.; Sopkova-de Oliveira Santos, J.; Bureau, R.; Clark, T. A Three-Site Mechanism for Agonist/Antagonist Selective Binding to Vasopressin Receptors. Angew. Chemie Int. Ed. 2016, 55, 8008–8012.
doi: 10.1002/anie.201602729

(129) Preshlock, S.; Calderwood, S.; Verhoog, S.; Tredwell, M.; Huiban, M.; Hienzsch, A.; Gruber, S.; Wilson, T. C.; Taylor, N. J.; Cailly, T.; Schedler, M.; Collier, T. L.; Passchier, J.; Smits, R.; Mollitor, J.; Hoepping, A.; Mueller, M.; Genicot, C.; Mercier, J.; Gouverneur, V. Enhanced Copper-Mediated 18 F-Fluorination of Aryl Boronic Esters Provides Eight Radiotracers for PET Applications. Chem. Commun. 2016, 52, 8361–8364.
doi: 10.1039/C6CC03295H

(128) Yahiaoui, S.; Hamidouche, K.; Ballandonne, C.; Davis, A.; de Oliveira Santos, J. S.; Freret, T.; Boulouard, M.; Rochais, C.; Dallemagne, P. Design, Synthesis, and Pharmacological Evaluation of Multitarget-Directed Ligands with Both Serotonergic Subtype 4 Receptor (5-HT4R) Partial Agonist and 5-HT6R Antagonist Activities, as Potential Treatment of Alzheimer’s Disease. Eur. J. Med. Chem. 2016, 121, 283–293.
doi: 10.1016/j.ejmech.2016.05.048

(127) Villain, J.; Minguez, L.; Halm-Lemeille, M.-P.; Durrieu, G.; Bureau, R. Acute Toxicities of Pharmaceuticals toward Green Algae. Mode of Action, Biopharmaceutical Drug Disposition Classification System and Quantile Regression Models. Ecotoxicol. Environ. Saf. 2016, 124, 337–343.
doi: 10.1016/j.ecoenv.2015.11.009

(126) Lalut, J.; Tournier, B. B.; Cailly, T.; Lecoutey, C.; Corvaisier, S.; Davis, A.; Ballandonne, C.; Since, M.; Millet, P.; Fabis, F.; Dallemagne, P.; Rochais, C. Synthesis and Evaluation of Novel Serotonin 4 Receptor Radiotracers for Single Photon Emission Computed Tomography. Eur. J. Med. Chem. 2016, 116, 90–101.
doi: 10.1016/j.ejmech.2016.03.059

(125) Jourdan, J.-P.; Since, M.; El Kihel, L.; Lecoutey, C.; Corvaisier, S.; Legay, R.; Sopkova-de Oliveira Santos, J.; Cresteil, T.; Malzert-Fréon, A.; Rochais, C.; Dallemagne, P. Novel Benzylidenephenylpyrrolizinones with Pleiotropic Activities Potentially Useful in Alzheimer’s Disease Treatment. Eur. J. Med. Chem. 2016, 114, 365–379.
doi: 10.1016/j.ejmech.2016.03.023

(124) Raj, S.; Krishnan, K.; Askew, D. S.; Helynck, O.; Suzanne, P.; Lesnard, A.; Rault, S.; Zeidler, U.; D’Enfert, C.; Latgé, J.-P.; Munier-Lehmann, H.; Saveanu, C. The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components. Antimicrob. Agents Chemother. 2016, 60, 1438–1449.
doi: 10.1128/AAC.02239-15

(123) Lam, B. V.; Berhault, Y.; Stiebing, S.; Fossey, C.; Cailly, T.; Collot, V.; Fabis, F. Iodoindazoles with Selective Magnesiation at Position 3: A Route to Highly Functionalized Indazoles. Chem. - A Eur. J. 2016, 22, 4440–4446.
doi: 10.1002/chem.201504828

(122) Gué, E.; Since, M.; Ropars, S.; Herbinet, R.; Le Pluart, L.; Malzert-Fréon, A. Evaluation of the Versatile Character of a Nanoemulsion Formulation. Int. J. Pharm. 2016, 498, 49–65.
doi: 10.1016/j.ijpharm.2015.12.010


(121) Rizza, P.; Pellegrino, M.; Caruso, A.; Iacopetta, D.; Sinicropi, M. S.; Rault, S.; Lancelot, J. C.; El-Kashef, H.; Lesnard, A.; Rochais, C.; Dallemagne, P.; Saturnino, C.; Giordano, F.; Catalano, S.; Andò, S. 3-(Dipropylamino)-5-hydroxybenzofuro[2,3-F]quinazolin-1(2H)-One (DPA-HBFQ-1) Plays an Inhibitory Role on Breast Cancer Cell Growth and Progression. Eur. J. Med. Chem. 2016, 107, 275–287.
doi: 10.1016/j.ejmech.2015.11.004

Télécharger la page

Dernière modification : 10 janvier 2017



Université de Caen Normandie
CERMN Centre détudes et de recherche sur le médicament de Normandie
Boulevard Becquerel | 14032 Caen Cedex | France